144 related articles for article (PubMed ID: 36912251)
1. Literature review: are NSAIDs harmful and is acetaminophen well tolerated?
Abbasi M; Teakell J
Curr Opin Nephrol Hypertens; 2023 May; 32(3):284-289. PubMed ID: 36912251
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort study.
Lipworth L; Abdel-Kader K; Morse J; Stewart TG; Kabagambe EK; Parr SK; Birdwell KA; Matheny ME; Hung AM; Blot WJ; Ikizler TA; Siew ED
BMC Nephrol; 2016 Nov; 17(1):189. PubMed ID: 27881100
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs in chronic kidney disease and risk of acute adverse kidney events according to route of administration.
Teo SH; Tan NC; Choo JCJ; Kwek JL; Kadir HBA; Bee YM; Huang H; Kaushik M; Ang ATW; Lim CC
Int Urol Nephrol; 2023 Mar; 55(3):679-686. PubMed ID: 36065044
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis.
Zhang X; Donnan PT; Bell S; Guthrie B
BMC Nephrol; 2017 Aug; 18(1):256. PubMed ID: 28764659
[TBL] [Abstract][Full Text] [Related]
5. NSAID-associated acute kidney injury in hospitalized children - a prospective Pediatric Nephrology Research Consortium study.
Misurac JM; Grinsell MM; Narus JH; Mason S; Kallash M; Andreoli SP
Pediatr Nephrol; 2023 Sep; 38(9):3109-3116. PubMed ID: 36943469
[TBL] [Abstract][Full Text] [Related]
6. Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study.
Hsu CC; Wang H; Hsu YH; Chuang SY; Huang YW; Chang YK; Liu JS; Hsiung CA; Tsai HJ
Hypertension; 2015 Sep; 66(3):524-33. PubMed ID: 26169048
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drugs and risk of acute adverse renal outcomes in diabetes and diabetic kidney disease.
Lim CC; Kadir HBA; Tan NC; Ang ATW; Bee YM; Lee PH; Goh BQ; Ang ALC; Xin X; Kwek JL; Lam AYR; Choo JCJ
Int J Risk Saf Med; 2022; 33(1):27-36. PubMed ID: 34397422
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study.
Abd ElHafeez S; Hegazy R; Naga Y; Wahdan I; Sallam S
J Egypt Public Health Assoc; 2019; 94(1):8. PubMed ID: 30799879
[TBL] [Abstract][Full Text] [Related]
9. Keeping kidneys safe: the pharmacist's role in NSAID avoidance in high-risk patients.
Pai AB
J Am Pharm Assoc (2003); 2015; 55(1):e15-23; quiz e24-5. PubMed ID: 25503987
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs.
Lucas GNC; Leitão ACC; Alencar RL; Xavier RMF; Daher EF; Silva Junior GBD
J Bras Nefrol; 2019; 41(1):124-130. PubMed ID: 30281062
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal Anti-inflammatory Drugs: Clinical Implications, Renal Impairment Risks, and AKI.
LaForge JM; Urso K; Day JM; Bourgeois CW; Ross MM; Ahmadzadeh S; Shekoohi S; Cornett EM; Kaye AM; Kaye AD
Adv Ther; 2023 May; 40(5):2082-2096. PubMed ID: 36947330
[TBL] [Abstract][Full Text] [Related]
12. Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector.
Meuwesen WP; du Plessis JM; Burger JR; Lubbe MS; Cockeran M
Int J Clin Pharm; 2016 Aug; 38(4):863-9. PubMed ID: 27091130
[TBL] [Abstract][Full Text] [Related]
13. Kidney damage from nonsteroidal anti-inflammatory drugs-Myth or truth? Review of selected literature.
Drożdżal S; Lechowicz K; Szostak B; Rosik J; Kotfis K; Machoy-Mokrzyńska A; Białecka M; Ciechanowski K; Gawrońska-Szklarz B
Pharmacol Res Perspect; 2021 Aug; 9(4):e00817. PubMed ID: 34310861
[TBL] [Abstract][Full Text] [Related]
14. Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics.
Whelton A
Am J Ther; 2000 Mar; 7(2):63-74. PubMed ID: 11319575
[TBL] [Abstract][Full Text] [Related]
15. NSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, upstate New York, 2011.
Jang SM; Cerulli J; Grabe DW; Fox C; Vassalotti JA; Prokopienko AJ; Pai AB
Prev Chronic Dis; 2014 Dec; 11():E220. PubMed ID: 25523351
[TBL] [Abstract][Full Text] [Related]
16. NSAIDs in CKD: Are They Safe?
Baker M; Perazella MA
Am J Kidney Dis; 2020 Oct; 76(4):546-557. PubMed ID: 32479922
[TBL] [Abstract][Full Text] [Related]
17. Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury.
Jones P; Dalziel SR; Lamdin R; Miles-Chan JL; Frampton C
Cochrane Database Syst Rev; 2015 Jul; (7):CD007789. PubMed ID: 26130144
[TBL] [Abstract][Full Text] [Related]
18. The case for cautious consumption: NSAIDs in chronic kidney disease.
Sriperumbuduri S; Hiremath S
Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):163-170. PubMed ID: 30531470
[TBL] [Abstract][Full Text] [Related]
19. Non-Steroidal Anti-Inflammatory Drugs and Risk of Acute Kidney Injury and Hyperkalemia in Older Adults: A Retrospective Cohort Study and External Validation of a Clinical Risk Model.
Lim CC; Tan NC; Teo EPS; Kadir HBA; Kwek JL; Bee YM; Ang ATW; Teo SH; Kaushik M; Tan CS; Choo JCJ
Drugs Aging; 2022 Jan; 39(1):75-82. PubMed ID: 34888761
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review.
Nderitu P; Doos L; Jones PW; Davies SJ; Kadam UT
Fam Pract; 2013 Jun; 30(3):247-55. PubMed ID: 23302818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
